Printer Friendly Version 

Investor Relations Home

Webcast ImageWebcast
Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2014 AAN Annual Meeting (Live)
04/29/14 at 6:00 p.m. ET
Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2014 AAN Annual Meeting
Tuesday, April 29, 2014 6:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
R&D Day (Live)
05/22/14 at 12:00 p.m. ET
R&D Day
Thursday, May 22, 2014 12:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Isis’ Annual Stockholder Meeting (Live)
06/10/14 at 5:10 p.m. ET
Isis’ Annual Stockholder Meeting
Tuesday, June 10, 2014 5:10 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
ISIS (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$35.20
Change (%) Stock is Down 1.8 (4.86%)
Volume1,599,270
Data as of 04/23/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Featured Report
2012 Interactive Annual Report

Recent Press ReleasesMore >>
DateTitle 
04/22/14Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at the 2014 AAN Annual Meeting
- Event and webcast scheduled on Tuesday, April 29 at 6:00 p.m. Eastern Time CARLSBAD, Calif., April 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will host an investor event and a live webcast on Tuesday, April 29, 2014 at 6:00 p.m. Eastern Time to discuss the ISIS-SMNRx data presented at the 2014 American Academy of Neurology Annual Meeting.  Interested parties may register to attend the event in Philadelphia, PA, or access the webcast on t... 
Printer Friendly Version
04/01/14Isis Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference
CARLSBAD, Calif., April 1, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 13th Annual Needham Healthcare Conference on Tuesday, April 8 , 2014 at 12:50 p.m. ET in New York, NY. A live webcast of the presentation will be available on the "Investors & Media" section of the Company's website, www.isispharm.com.  A replay will be available on the Isis website within ... 
Printer Friendly Version
03/31/14Isis Reports Final Phase 2 Data On ISIS-APOCIII Rx In Patients With High Triglycerides Taking Fibrates
- Reductions of up to 64 percent in triglycerides achieved - Reductions in atherogenic particles and increases in HDL particles observed - Data presented today at the American College of Cardiology CARLSBAD, Calif., March 31, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final results from its Phase 2 study of ISIS-APOCIIIRx in patients with high to severely high triglycerides on stable doses of fibrates.  In this study, patients treated with ISIS-APOCIIIR... 
Printer Friendly Version
03/24/14Isis Announces Antisense Targeting Of HBV Produces Dose-Dependent Reductions In Hepatitis B Virus In An Animal Model Of HBV
Data to be presented in April at the European Association for the Study of the Liver Meeting Isis' antisense drug targeting HBV, ISIS-HBVRx, in an ongoing Phase 1 study planned to complete this year CARLSBAD, Calif., March 24, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that treatment with an antisense compound targeting hepatitis B virus (HBV) produced dose-dependent reductions in all measured liver and serum viral markers of HBV infection in animal models of ... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
04/26/14
through
05/03/14
AAN 2014 Annual Meeting
LocationPhiladelphia, PA
04/27/14
through
05/01/14
XIVth International Symposium on Amyloidosis
LocationIndianapolis, IN
04/29/14 6:00 p.m. ET
Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2014 AAN Annual Meeting
LocationPhiladelphia, PA
05/01/14
through
05/03/14
ATVB 2014
LocationToronto, Ontario
05/01/14
through
05/04/14
NLA Scientific Sessions 2014
LocationOrlando, FL
05/04/14
through
05/08/14
ARVO 2014
LocationOrlando, FL
Primary IR Contact
D. Wade Walke, Ph.D.
Vice President, Corporate Communications and Investor Relations
Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010
Phone: 760-603-2331

For more information requests, please visit our Information Request page.

If you are interested in Isis Pharmaceuticals’ investment details,
please visit our Investor FAQ page.


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Online Investor Kit

Quickly download files right from our Investor Relations Web site.

Learn More

Financial Tearsheet

Download a brief overview of Isis.

Learn More

News Feeds

Get the latest.

Subscribe

Receive Isis alerts in your email.

Sign Up